Skip to main content
. Author manuscript; available in PMC: 2023 Jan 25.
Published in final edited form as: Circulation. 2021 Dec 8;145(4):259–267. doi: 10.1161/CIRCULATIONAHA.121.056705

Table 3.

Multivariable-adjusted hazard ratios (95% confidence interval) for the association of cardiovascular risk factors and incident atherosclerotic cardiovascular disease and all-cause mortality among those with coronary artery calcium 0 at baseline

ASCVD All-Cause Mortality
Cigarette smoking status
Never 1.00 (ref) 1.00 (ref)
Former 1.07 (0.71,1.61) 1.04 (0.79,1.38)
Current 2.12 (1.32,3.42) 2.66 (1.89,3.74)
Diabetes mellitus 1.68 (1.01,2.80) 1.13 (0.78,1.63)
Hypertension 1.57 (1.06,2.33) 1.37 (1.03,1.81)
Aspirin use 1.06 (0.66,1.69) 0.79 (0.57,1.10)
Time varying statin use 0.81 (0.53,1.24) 0.79 (0.59,1.05)
Waist circumference, per 10 cm 1.05 (0.91,1.20) 1.10 (1.00,1.21)
Family history of premature ASCVD 1.30 (0.86,1.96) 0.83 (0.59,1.17)
Chronic kidney disease 1.23 (0.77,1.95) 1.14 (0.84,1.53)
HDL-C, per 10 mg/dL 0.92 (0.79,1.06) 0.96 (0.87,1.07)
Triglycerides, per 10 mg/dL 1.00 (0.97,1.03) 0.99 (0.97,1.02)
LDL-C, per 10 mg/dL 0.99 (0.94,1.05) 0.97 (0.92,1.01)
*Lp(a), per 5 mg/dL 1.07 (0.46,2.49) 1.21 (0.66,2.22)
*hsCRP, per mg/L 1.00 (0.84,1.19) 1.12 (0.99,1.26)

Abbreviations: SBP (systolic blood pressure); CHD (coronary heart disease); HDL-C (high-density lipoprotein cholesterol); LDL-C (low-density lipoprotein cholesterol); Lp(a) (lipoprotein (a)); hsCRP (high-sensitivity C-reactive protein).

*

Lp(a) and hsCRP are log-transformed

Model is adjusted for age, sex, race/ethnicity, education, presence of healthcare insurance and all listed risk factors

BOLDED items are significant statistically significant (P < 0.05)